Seven Eight Capital LP Has $927,000 Holdings in agilon health, inc. (NYSE:AGL)

Seven Eight Capital LP lessened its position in shares of agilon health, inc. (NYSE:AGL) by 45.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,719 shares of the company’s stock after selling 119,507 shares during the period. Seven Eight Capital LP’s holdings in agilon health were worth $927,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of AGL. Scotia Capital Inc. lifted its position in shares of agilon health by 1.3% in the fourth quarter. Scotia Capital Inc. now owns 132,576 shares of the company’s stock worth $1,664,000 after purchasing an additional 1,741 shares in the last quarter. Arizona State Retirement System lifted its position in agilon health by 2.5% during the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after buying an additional 2,070 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its stake in shares of agilon health by 31.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock worth $113,000 after buying an additional 2,149 shares during the last quarter. Swiss National Bank grew its holdings in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after acquiring an additional 3,400 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of agilon health in the fourth quarter valued at about $45,000.

agilon health Stock Down 9.0 %

AGL stock opened at $3.52 on Friday. agilon health, inc. has a fifty-two week low of $3.07 and a fifty-two week high of $20.37. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -5.03 and a beta of 0.54. The business’s fifty day moving average price is $5.22 and its two-hundred day moving average price is $5.54.

agilon health (NYSE:AGL) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health’s revenue for the quarter was up 38.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.04) earnings per share. On average, equities analysts anticipate that agilon health, inc. will post -0.32 earnings per share for the current year.

Insider Activity at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 3.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on AGL shares. Baird R W upgraded agilon health to a “hold” rating in a research note on Thursday, May 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Truist Financial lifted their price objective on shares of agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a research report on Friday, May 24th. Benchmark reaffirmed a “buy” rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Finally, Evercore ISI lifted their price target on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $8.57.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.